Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
E. Donnall Thomas(National Cancer Center), Henri Roché(Institut Claudius Regaud), Valorie F. Chan(National Cancer Center), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xavier Pivot(Centre Hospitalier Universitaire de Besançon), Henry Gómez(National Cancer Center), F Mendoza(National Cancer Center), Linda T. Vahdat(Dartmouth College), Luis Fein(National Cancer Center), Judith Klimovsky(National Cancer Center), Mario Campone(Institut de Cancérologie de l'Ouest), Rubi K. Li(National Cancer Center), Guillermo Lerzo, Hyun Cheol Chung(Yonsei University Health System), Jacek Jassem
Cited by 483
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k